Westside Investment Management’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $157K | Sell |
3,284
-1,146
| -26% | -$49.2K | 0.02% | 347 |
|
|
2026
Q1 | $163K | Sell |
4,430
-200
| -4% | -$9.48K | 0.03% | 321 |
|
|
2025
Q4 | $238K | Buy |
4,630
+1,800
| +64% | +$92K | 0.04% | 254 |
|
|
2025
Q3 | $161K | Buy |
2,830
+473
| +20% | +$27.7K | 0.03% | 315 |
|
|
2025
Q2 | $163K | Buy |
2,357
+473
| +25% | +$32.2K | 0.03% | 278 |
|
|
2025
Q1 | $131K | Buy |
1,884
+58
| +3% | +$4.79K | 0.03% | 282 |
|
|
2024
Q4 | $157K | Hold |
1,826
| – | – | 0.03% | 258 |
|
|
2024
Q3 | $218K | Hold |
1,826
| – | – | 0.05% | 225 |
|
|
2024
Q2 | $261K | Buy |
1,826
+398
| +28% | +$52.7K | 0.06% | 200 |
|
|
2024
Q1 | $183K | Hold |
1,428
| – | – | 0.04% | 240 |
|
|
2023
Q4 | $148K | Hold |
1,428
| – | – | 0.04% | 240 |
|
|
2023
Q3 | $130K | Sell |
1,428
-130
| -8% | -$11.5K | 0.04% | 243 |
|
|
2023
Q2 | $126K | Hold |
1,558
| – | – | 0.04% | 250 |
|
|
2023
Q1 | $124K | Sell |
1,558
-200
| -11% | -$14.2K | 0.04% | 250 |
|
|
2022
Q4 | $118 | Buy |
1,758
+558
| +47% | +$32.7K | ﹤0.01% | 352 |
|
|
2022
Q3 | $59 | Hold |
1,200
| – | – | ﹤0.01% | 400 |
|
|
2022
Q2 | $66 | Hold |
1,200
| – | – | ﹤0.01% | 386 |
|
|
2022
Q1 | $66 | Hold |
1,200
| – | – | ﹤0.01% | 396 |
|
|
2021
Q4 | $67 | Hold |
1,200
| – | – | ﹤0.01% | 381 |
|
|
2021
Q3 | $57 | Hold |
1,200
| – | – | ﹤0.01% | 381 |
|
|
2021
Q2 | $50 | Hold |
1,200
| – | – | ﹤0.01% | 385 |
|
|
2021
Q1 | $40 | Hold |
1,200
| – | – | ﹤0.01% | 394 |
|
|
2020
Q4 | $41 | Hold |
1,200
| – | – | ﹤0.01% | 360 |
|
|
2020
Q3 | $41 | Hold |
1,200
| – | – | ﹤0.01% | 361 |
|
|
2020
Q2 | $39 | Hold |
1,200
| – | – | ﹤0.01% | 352 |
|
|
2020
Q1 | $36 | Buy |
+1,200
| New | +$35.7K | ﹤0.01% | 357 |
|
|
2019
Q2 | $193K | Buy |
+7,600
| New | +$188K | 0.07% | 163 |
|
|
2018
Q4 | $417K | Hold |
18,100
| – | – | 0.15% | 98 |
|
|
2018
Q3 | $421K | Sell |
18,100
-1,000
| -5% | -$24.4K | 0.13% | 97 |
|
|
2018
Q2 | $448K | Buy |
19,100
+750
| +4% | +$17.8K | 0.16% | 88 |
|
|
2018
Q1 | $444K | Hold |
18,350
| – | – | 0.24% | 86 |
|
|
2017
Q4 | $502K | Hold |
18,350
| – | – | 0.27% | 78 |
|
|
2017
Q3 | $451K | Sell |
18,350
-108
| -0.6% | -$2.44K | 0.27% | 82 |
|
|
2017
Q2 | $389K | Sell |
18,458
-1,000
| -5% | -$20.2K | 0.25% | 90 |
|
|
2017
Q1 | $347K | Buy |
19,458
+6,800
| +54% | +$118K | 0.17% | 90 |
|
|
2016
Q4 | $225K | Buy |
+12,658
| New | +$229K | 0.15% | 88 |
|
Other funds holding NVO
F
Westside Investment Management's NVO Position: Q2 2026 in Review
Westside Investment Management reduced its Novo Nordisk (NVO) stake by 26% in Q2 2026, selling an estimated $49.2K and leaving 3,284 shares worth $157K. The position accounts for 0.02% of the portfolio, ranked #347.
Westside Investment Management first reported a position in NVO in Q4 2016 and has held it in 36 quarters since. The position peaked at $502K in Q4 2017. 1,350 funds tracked by Wall St. Rank hold NVO as of Q2 2026.
- Westside Investment Management held 3,284 shares of Novo Nordisk worth $157K as of Q2 2026.
- Westside Investment Management sold 1,146 Novo Nordisk shares in Q2 2026, an estimated $49.2K.
- Novo Nordisk made up 0.02% of Westside Investment Management's portfolio in Q2 2026, its #347 holding.
- Westside Investment Management first reported a position in Novo Nordisk in Q4 2016 and has held it in 36 quarters since.
- Westside Investment Management's Novo Nordisk position peaked at $502K in Q4 2017.
- 1,350 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.
Based on Westside Investment Management's 13F filing for Q2 2026, filed 27 Jul 2026.